{
  "docId": "019dd923-5fed-74f2-a970-7e7c18dd4509",
  "docSlug": "bi-4a377eb8046117c7",
  "documentTitle": "Odaia's pitch deck for its $25 million Series B funding round",
  "authorId": "Pitchdecks",
  "authorName": "Odaia",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 5,
  "pageCount": 14,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "Uses two large circles to represent the total market and the specific segment being addressed.",
  "elementsJson": [
    "action_title",
    "big_number",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fed-74f2-a970-7e7c18dd4509/5",
  "deckHref": "/decks/019dd923-5fed-74f2-a970-7e7c18dd4509",
  "deckJsonHref": "/decks/019dd923-5fed-74f2-a970-7e7c18dd4509.json",
  "deckAnchorHref": "/decks/019dd923-5fed-74f2-a970-7e7c18dd4509#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.35,
        "x": 0.55,
        "y": 0.25
      },
      "kind": "metric",
      "text": "Of that... $20B Is spent on Sales and Marketing Directly to Physicians",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5b8c0744-6ebe-40b5-94ca-783600899b39",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.35,
        "x": 0.15,
        "y": 0.25
      },
      "kind": "metric",
      "text": "$30B Spent on Sales and Marketing in the US alone",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f98f39d8-7682-4d50-8512-32e340ac8c3b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Sales and Marketing Spend: $30B",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-b668-75ec-8e52-1c5422416b81",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.7,
        "x": 0.15,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "Source: Schwartz LM, Woloshin S. Medical Marketing in the United States, 1997-2016. JAMA. 2019;321(1):80–96. doi:10.1001/jama.2018.19320",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c81c3dba-917c-4a39-983b-b2639dbedd12",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "ODAIA is Tackling Pharma's Highly Inefficient Commercial Process",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2a8ca838-2029-44c8-a29d-31959f6c1b24",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 5,
      "beatId": "1d954e87-7df3-42f4-a6ec-21a84576242b",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "Clear problem statement",
      "position": 0,
      "confidence": 0.9,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 8,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "dbabb9c4-fbf7-4446-9d68-f77eeb447491",
      "evidence": "Problem statement and context",
      "position": 0,
      "objective": "Highlight the cost of not addressing pharma's commercial inefficiency",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.8,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}